FI960849L - Metallikomplekseja sisältäviä farmaseuttisia koostumuksia - Google Patents

Metallikomplekseja sisältäviä farmaseuttisia koostumuksia Download PDF

Info

Publication number
FI960849L
FI960849L FI960849A FI960849A FI960849L FI 960849 L FI960849 L FI 960849L FI 960849 A FI960849 A FI 960849A FI 960849 A FI960849 A FI 960849A FI 960849 L FI960849 L FI 960849L
Authority
FI
Finland
Prior art keywords
pharmaceutical compositions
compositions containing
metal complexes
containing metal
complexes
Prior art date
Application number
FI960849A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI960849A0 (fi
FI960849A7 (fi
Inventor
Michael Jeffrey Abrams
Simon Paul Fricker
Barry Anthony Murrer
Owen John Vaughan
Original Assignee
Johnson Matthey Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson Matthey Plc filed Critical Johnson Matthey Plc
Publication of FI960849A0 publication Critical patent/FI960849A0/fi
Publication of FI960849A7 publication Critical patent/FI960849A7/fi
Publication of FI960849L publication Critical patent/FI960849L/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Inorganic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Hospice & Palliative Care (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Psychiatry (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI960849A 1993-08-25 1994-08-19 Metallikomplekseja sisältäviä farmaseuttisia koostumuksia FI960849L (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939317686A GB9317686D0 (en) 1993-08-25 1993-08-25 Pharmaceutical compositions
PCT/GB1994/001817 WO1995005814A1 (en) 1993-08-25 1994-08-19 Pharmaceutical compositions comprising metal complexes

Publications (3)

Publication Number Publication Date
FI960849A0 FI960849A0 (fi) 1996-02-23
FI960849A7 FI960849A7 (fi) 1996-02-23
FI960849L true FI960849L (fi) 1996-02-23

Family

ID=10741021

Family Applications (1)

Application Number Title Priority Date Filing Date
FI960849A FI960849L (fi) 1993-08-25 1994-08-19 Metallikomplekseja sisältäviä farmaseuttisia koostumuksia

Country Status (14)

Country Link
US (1) US5824673A (enExample)
EP (1) EP0714294A1 (enExample)
JP (1) JPH09501927A (enExample)
KR (1) KR100331978B1 (enExample)
AU (1) AU698785B2 (enExample)
CA (1) CA2170253A1 (enExample)
FI (1) FI960849L (enExample)
GB (1) GB9317686D0 (enExample)
HU (1) HUT74947A (enExample)
NO (1) NO960754L (enExample)
NZ (1) NZ269596A (enExample)
TW (1) TW282401B (enExample)
WO (1) WO1995005814A1 (enExample)
ZA (1) ZA946262B (enExample)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6417182B1 (en) * 1993-08-25 2002-07-09 Anormed Inc. Pharmaceutical compositions comprising metal complexes
DK0758890T3 (da) * 1994-05-11 2005-04-18 Jes Olesen Anvendelse af NO indfangere, inhibitorer eller antagonister ved behandling af migræne
CN1222286C (zh) * 1994-05-13 2005-10-12 孟山都公司 过亚硝酸盐分解催化剂的应用方法及其药物组合物
US6245758B1 (en) 1994-05-13 2001-06-12 Michael K. Stern Methods of use for peroxynitrite decomposition catalysts, pharmaceutical compositions therefor
US6743771B2 (en) * 1995-12-29 2004-06-01 Novactyl, Inc. Methods and compositions for controlling protein assembly or aggregation
US20030013772A1 (en) * 2000-02-23 2003-01-16 Murphy Michael A. Composition, synthesis and therapeutic applications of polyamines
DE19860289C2 (de) * 1998-12-21 2003-11-13 Schering Ag Neue Chelatoren sowie deren Tricarbonyl-Komplexe mit Technetium und Rhenium
AU3268500A (en) * 1999-03-19 2000-10-09 Anormed Inc. Pharmaceutical compositions comprising metal complexes
WO2001014592A2 (en) * 1999-08-25 2001-03-01 Clarity Biosciences, Inc. Identifying organisms by detecting intronic nucleic acid or encoded proteins
US7335383B2 (en) * 2001-01-16 2008-02-26 The Regents Of The University Of Michigan Generation of nitric oxide in vivo from nitrite, nitrate or nitrosothiols endogenous in blood
US7128904B2 (en) * 2001-01-16 2006-10-31 The Regents Of The University Of Michigan Material containing metal ion ligand complex producing nitric oxide in contact with blood
US20040170998A1 (en) * 2001-03-01 2004-09-02 Honeycutt Rhonda J. Methods of making and uses of compositions that modulate intronic region-encoded protein function
GB0111872D0 (en) * 2001-05-15 2001-07-04 Northwick Park Inst For Medica Therapeutic agents and methods
US7968605B2 (en) * 2002-02-04 2011-06-28 ALFAMA—Investigação e Desenvolvimento de Produtos Farmacêuticos, Lda. Methods for treating inflammatory disease by administering aldehydes and derivatives thereof
NZ534912A (en) * 2002-02-04 2007-08-31 Alfama Investigacao E Desenvol supramolecule aggregate comprising CO containing organometallic or transition metal complex and anti-inflammatory agent or biphosphonate phosphonate derivative
US20080026984A1 (en) * 2002-02-04 2008-01-31 Alfama - Investigacao E Desenvolvimento De Productos Farmaceuticos Lda Methods for treating inflammatory disease by administering aldehydes and derivatives thereof
GB2395432B (en) * 2002-11-20 2005-09-14 Northwick Park Inst For Medica Therapeutic delivery of carbon monoxide to extracorporeal and isolated organs
US20070207217A1 (en) * 2003-02-03 2007-09-06 Alfama - Investigacao E Desenvolvimento De Productos Farmaceuticos Lda Method for treating a mammal by administration of a compound having the ability to release CO
CN1318430C (zh) * 2003-04-24 2007-05-30 钟文远 一类稀土配合物及其制备方法和在制备治疗肿瘤药物中的应用
CA2549570A1 (en) * 2003-11-07 2005-05-19 Shetech Co., Ltd. Medicament for prophylactic and/or therapeutic treamtent of cerebral infarction
US20060008529A1 (en) * 2004-07-12 2006-01-12 Meyerhoff Mark E Use of additive sites to control nitric oxide release from nitric oxide donors contained within polymers
US20060039950A1 (en) * 2004-08-23 2006-02-23 Zhengrong Zhou Multi-functional biocompatible coatings for intravascular devices
US20080241208A1 (en) * 2005-06-30 2008-10-02 Charles Shanley Methods, Compositions and Devices For Promoting Anglogenesis
JP2009518069A (ja) * 2005-12-02 2009-05-07 ザ・リージェンツ・オブ・ザ・ユニバーシティ・オブ・ミシガン 組成物、コーティング及びデバイス、並びにそれらの製造方法及び使用方法
GB0601394D0 (en) 2006-01-24 2006-03-01 Hemocorm Ltd Therapeutic delivery of carbon monoxide
US20080119002A1 (en) * 2006-11-17 2008-05-22 Charles Grosjean Substrate contact for a MEMS device
US8597563B2 (en) 2008-07-11 2013-12-03 Rohm And Haas Company Recycled thermoplastic composition comprising waste thermoset material and methods of making
DE102010014411A1 (de) 2010-04-08 2011-10-13 Friedrich-Schiller-Universität Jena Kohlenmonoxid und Eisen freisetzende Moleküle, deren Verwendung und Verfahren zu deren Herstellung
DE102010014412A1 (de) 2010-04-08 2012-04-19 Friedrich-Schiller-Universität Jena Verwendung von zweikernigen Eisenkomplexen mit schwefelhaltigen Liganden als pharmakologische Wirkstoffe
WO2012138988A2 (en) * 2011-04-07 2012-10-11 The Research Foundation Of The City University Of New York Organometallic anti-cancer complexes
EP2699242B1 (en) 2011-04-19 2017-11-01 Alfama, Inc. Carbon monoxide releasing molecules and uses thereof
JP6134710B2 (ja) 2011-07-21 2017-05-24 アルファーマ インコーポレイテッドＡｌｆａｍａ，Ｉｎｃ． 一酸化ルテニウム放出分子およびその使用
DE102012004132A1 (de) 2012-02-29 2013-08-29 Friedrich-Schiller-Universität Jena Kohlenstoffmonoxid freisetzende Materialien und deren Verwendung
DE102014008537A1 (de) 2014-06-04 2015-12-17 Friedrich-Schiller-Universität Jena Wasserlösliche manganbasierte Kohlenstoffmonoxid freisetzende Moleküle, deren Verwendung und Verfahren zu deren Herstellung

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1482811A (fr) * 1960-01-26 1967-06-02 Australian Nat University Pers Nouveaux complexes métallifères d'agents de coordination homogènes, et leur procédé de préparation
EP0191096B1 (de) * 1984-07-24 1989-09-13 ASTA Pharma AG Tumorhemmend wirkende rutheniumverbindungen
WO1986000804A1 (fr) * 1984-07-24 1986-02-13 Byk Gulden Lomberg Chemische Fabrik Gesellschaft M Compositions de ruthenium a effet inhibiteur de tumeurs
US5157032A (en) * 1985-01-18 1992-10-20 The Trustees Of Columbia University In The City Of New York Mixed ligand complexes and uses thereof as binding agents and probes to DNA
IT1230145B (it) * 1989-05-05 1991-10-14 Boehringer Biochemia Srl Complessi di rutenio (iii) come agenti antineoplastici.

Also Published As

Publication number Publication date
FI960849A0 (fi) 1996-02-23
KR960703609A (ko) 1996-08-31
WO1995005814A1 (en) 1995-03-02
CA2170253A1 (en) 1995-03-02
HU9600441D0 (en) 1996-04-29
HUT74947A (en) 1997-03-28
NO960754L (no) 1996-04-23
FI960849A7 (fi) 1996-02-23
US5824673A (en) 1998-10-20
JPH09501927A (ja) 1997-02-25
NZ269596A (en) 1997-05-26
AU7390794A (en) 1995-03-21
KR100331978B1 (ko) 2002-09-26
ZA946262B (en) 1995-03-20
EP0714294A1 (en) 1996-06-05
TW282401B (enExample) 1996-08-01
NO960754D0 (no) 1996-02-23
AU698785B2 (en) 1998-11-05
GB9317686D0 (en) 1993-10-13

Similar Documents

Publication Publication Date Title
FI960849A0 (fi) Metallikomplekseja sisältäviä farmaseuttisia koostumuksia
PT589843E (pt) Composicoes farmaceuticas contendo ciclosporinas
FI944832A0 (fi) Farmaseuttinen koostumus
FI955144L (fi) Päällystetyt farmaseuttiset koostumukset
FI945524A7 (fi) Aerosolilääkekoostumuksia
GB9408842D0 (en) Pharmaceutical compositions for topical application
GB9317610D0 (en) Pharmaceutical compositions
ITRM920349A0 (it) Composizioni farmaceutiche contenenti il-6
ITMI932540A0 (it) Composizione farmaceutica
FI943452L (fi) Organosiloksaanisidotut transitiometallikompleksit
FI943705L (fi) Farmaseuttiset koostumukset
FI940726L (fi) Farmaseuttiset koostumukset
GB9317504D0 (en) Pharmaceutical compositions
LV10579A (lv) Farmaceitiska kompozicija
FI962979L (fi) Hirudiinia sisältävät farmaseuttiset koostumukset
FI934387A0 (fi) 3-substituerade 2-oxi-indol-1-karboxiamid omfattande farmaceutiska kompositioner
HU9401771D0 (en) Pharmaceutical compositions cintaining ipsapiron
ITMI930181A1 (it) Composizione farmaceutica contenente n-acetil-cisteina
SG47980A1 (en) Pharmaceutical compositions
ITMI922580A1 (it) Composizione farmaceutica
SE9202820D0 (sv) Farmaceutisk komposition
ITMI922581A1 (it) Composizione farmaceutica
BR1100200A (pt) Composição farmacêutica
ITMI932543A0 (it) Composizione farmaceutica
GB9311058D0 (en) Pharmaceutical compositions